1. bobbsmit40
2. gilsteil
3. jdujr
1.jdujr 03/07/2018
Signs a license agreement granting Roivant Sciences exclusive global rights to develop and commercialize LGD…
2.jdujr 06/28/2018
Raises FY18 EPS to $6.15 from $4.85
3.bobbsmit40 08/07/2018
Sees FY18 revs of $232 mln vs. $227.36 mln
4.gilsteil 02/02/2018
RELEASED - H.C. Wainwright & Co. reiterates Buy rating, $170 PT
5.bobbsmit40 01/22/2018
Ligand Pharmaceuticals enters into platform license agreement
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW